Molecular Diagnostics Market Is Expected to Benefit from the Increasing Investments in R&D of Improved Molecular Diagnostic Kits That Deliver Accurate Results
The global molecular diagnostics market is highly consolidated in nature, observes Transparency Market Research. The leading players accounted for a share of 54% in the overall market in 2015. F. Hoffman-La Roche Ltd., Abbott Laboratories, and Danaher Corporation have dominated the global market in the past few years. The broad product portfolio and strategic mergers and acquisitions have been the winning strategies of these players to remain dominant.
View full press release